TOTUS MEDICINES
Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome.
TOTUS MEDICINES
Industry:
Biopharma Biotechnology Medical
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.totusmedicines.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag
Similar Organizations
NeoScientific
NeoScientific is a dynamic and growing provider of high-quality biology research reagents, tools, and custom services.
Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Northpond Ventures
Northpond Ventures investment in Series A - Totus Medicines
Camford Capital
Camford Capital investment in Series A - Totus Medicines
DCVC Bio
DCVC Bio investment in Series A - Totus Medicines
Social Impact Capital
Social Impact Capital investment in Seed Round - Totus Medicines
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-23 | Totus Medicines Hires Corporate Strategy Leader Laura Miller |
Official Site Inspections
http://www.totusmedicines.com Semrush global rank: 4.22 M Semrush visits lastest month: 2.79 K
- Host name: 434307.cloudwaysapps.com
- IP address: 157.245.82.48
- Location: North Bergen United States
- Latitude: 40.793
- Longitude: -74.0247
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07047
More informations about "Totus Medicines"
Totus | Totus Medicines
Researchers have discovered hundreds of drug targets to treat diseaseโand find more every day. But until recently, 90 % of these targets have been considered โ undruggable,โ and โฆSee details»
Totus Medicines - Crunchbase Company Profile & Funding
Totus Medicines may be growing as evidenced by the closing of a significant Series B funding round, which amounted to $66 million. This substantial influx of capital typically indicates โฆSee details»
Mila partners with Totus Medicines to advance drug โฆ
Mar 23, 2022 About Totus Medicines Founded in 2019, Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome. Totus is based in โฆSee details»
Platform - Totus
Exponentially evolving covalent library We have the worldโs most comprehensive library of covalent chemistries, and as The Totus Platform learns, that library grows.See details»
Totus Medicines - LinkedIn
Totus Medicines | 3,063 followers on LinkedIn. Making every disease treatable by making the total human genome druggable. | Totus Medicines is applying revolutionary chemical biology technologies ...See details»
Totus Medicines - PitchBook
Totus Medicines General Information Description. Developer of chemical biology technologies designed to create therapeutics for untreatable diseases. The company's technology uses the โฆSee details»
Totus Medicines - Overview, News & Similar companies - ZoomInfo
Jan 1, 2024 Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358 for the Treatment Of Select Solid Tumors TOS-358 is the first highly specific, potent inhibitor of PI3Kฮฑ โฆSee details»
Totus Medicines - Craft
Totus Medicines has 5 employees at their 1 location and $40 m in total funding,. See insights on Totus Medicines including office locations, competitors, revenue, financials, executives, โฆSee details»
Totus Medicines - VentureRadar
"The Totus Platform discovers drugs with unprecedented volume, speed, and efficiency, allowing us to create a comprehensive catalog of drugs across the entire human genome.See details»
Totus Medicines CEO and Key Executive Team | Craft.co
Totus Medicines's Chief Data Officer is John Davies. Other executives include Neil Dhawan, Co-Founder, Chief Executive Officer, Chief Scientific Officer & Director; Alun Bermingham, Senior โฆSee details»
Totus Medicines - Products, Competitors, Financials, Employees ...
Totus is developing TOS-358, a covalent PI3Kฮฑ inhibitor in a Phase 1b clinical trial and is developing potent and selective covalent inhibitors of several other targets internally and has a โฆSee details»
Totus Medicines Emerges from Stealth with Revolutionary Drug โฆ
Dec 9, 2021 For more information, please visit totusmedicines.com and follow Totus on LinkedIn and Twitter. Media Contact: Megan O'Leary [email protected] (202) 331-1002. SOURCE Totus โฆSee details»
Totus Medicines Partners with Mila to Advance Drug Discovery ...
Mar 24, 2022 Mila is a nonprofit organization recognized worldwide for its significant contributions to the field of deep learning, particularly in language modeling, machine โฆSee details»
Totus Medicines - Work in biotech
Totus Medicines is using chemical biology to make the entire human genome druggable. Currently, 90% of targets to treat disease are considered โundruggableโ, and Totus Medicine โฆSee details»
Totus | Article
For more information, please visit totusmedicines.com and follow Totus on LinkedIn and Twitter/X. Contact: [email protected]. External Contact: Brian Mullen. LifeSci Advisors, LLC โฆSee details»
Introducing Totus Medicines - One Design Company
CHICAGO, December 9, 2021 โ Join us in celebrating the official launch of Totus Medicines, a chemical biology company seeking to make every disease treatable by making the entire โฆSee details»
Totus | Article - totusmedicines.com
"We are thrilled to announce our move to the Bay Area, a transition that sets the stage for our planned rapid growth," said Totus CEO and founder Neil Dhawan, Ph.D. "The Bay Area is a โฆSee details»
Inside the futuristic biotech startup Cellares thatโs building a cure ...
2 days ago Inside the futuristic biotech startup Cellares thatโs building a cure for cancer with $355 million in fundingSee details»
Totus | Clinical Trials - totusmedicines.com
For more information and a list of participating clinical trial sites, clinicaltrials.gov Study NCT05683418 or email [email protected] Totus Medicines. Our lifeโs work is โฆSee details»
Totus | Category - totusmedicines.com
Oct 19, 2023 Applying revolutionary chemical biology technologies to create life-changing covalent therapeutics for untreatable diseases.See details»